Amyris To Launch Its Biossance TM Clean Beauty Brand In China Through Partnership With Superordinary

Amyris, a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that it will be launching its Biossance Clean Beauty skincare brand into the Greater China market through a partnership with SuperOrdinary Group.

SuperOrdinary is the leading Clean Beauty marketing platform in China for some of the world’s fastest growing brands. China is one of the largest and fastest growing beauty markets globally, and the Chinese consumer is demanding sustainable products with clean ingredients. SuperOrdinary’s goal to bring the leading beauty and wellness brands to the China market aligns well with Biossance’s leadership in Clean Beauty and growth ambition.

Recommended AI News: Aisera Recognized as a Great Place to Work Company in 2020

“We work with best-in-class global beauty and cosmetics brands to establish and scale their influence and sales channels in China,” said Julian Reis, Founder and CEO of SuperOrdinary Group. “We are excited to partner with Amyris to bring its leading Biossance Clean Beauty brand to the Chinese consumer. We have a proven track record of working with high growth brands such as Biossance and are looking forward to delivering on Amyris’s vision for the Greater China market.”

Recommended AI News: Insilico Enters Into a Collaboration With Aprinoia to Apply Novel Generative AI-Powered System to Discover Novel Compounds for Neurodegenerative Diseases

“We are very pleased to partner with SuperOrdinary for our Biossance market entry in China. China is one of the largest growth markets for Clean Beauty and skincare and the Biossance brand is well positioned to join the winning portfolio represented by SuperOrdinary,” commented John Melo, President and Chief Executive Officer of Amyris. “Our consumer brands experienced an excellent fourth quarter with Biossance leading the way, and we expect our Consumer business to close out the fourth quarter with as much sales revenue as it recorded for all of 2019. We are very excited to take the momentum we have with Biossance to the China market.”

Recommended AI News: Boston Omaha Corporation Completes the Acquisition of Utah Broadband, LLC